David J Mauro Prelude Therapeutics Inc (PRLD) insider trading activity

PRLD Quotes by TradingView

David J Mauro is Chief Medical Officer of Prelude Therapeutics Inc. Currently has a direct ownership of 0 shares of PRLD, which is worth approximately $0. The most recent transaction as insider was on Oct 05, 2021, when has been sold 15,000 shares (Common Stock) at a price of $31.21 per share, resulting in proceeds of $468,150. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

David J Mauro Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 05 2021
SELL
Open market or private sale
$468,150 $31.21 p/Share
15,000 Reduced 100.0%
0 Common Stock
Oct 05 2021
BUY
Exercise of conversion of derivative security
$28,350 $1.89 p/Share
15,000 Added 50.0%
15,000 Common Stock
Sep 07 2021
SELL
Open market or private sale
$553,050 $36.87 p/Share
15,000 Reduced 100.0%
0 Common Stock
Sep 07 2021
BUY
Exercise of conversion of derivative security
$28,350 $1.89 p/Share
15,000 Added 50.0%
15,000 Common Stock
Aug 05 2021
SELL
Open market or private sale
$471,600 $31.44 p/Share
15,000 Reduced 100.0%
0 Common Stock
Aug 05 2021
BUY
Exercise of conversion of derivative security
$28,350 $1.89 p/Share
15,000 Added 50.0%
15,000 Common Stock
Jul 06 2021
SELL
Open market or private sale
$420,750 $28.05 p/Share
15,000 Reduced 100.0%
0 Common Stock
Jul 06 2021
BUY
Exercise of conversion of derivative security
$28,350 $1.89 p/Share
15,000 Added 50.0%
15,000 Common Stock
Jun 07 2021
SELL
Open market or private sale
$473,550 $31.57 p/Share
15,000 Reduced 100.0%
0 Common Stock
Jun 07 2021
BUY
Exercise of conversion of derivative security
$28,350 $1.89 p/Share
15,000 Added 50.0%
15,000 Common Stock
May 05 2021
SELL
Open market or private sale
$603,600 $40.24 p/Share
15,000 Reduced 100.0%
0 Common Stock
May 05 2021
BUY
Exercise of conversion of derivative security
$28,350 $1.89 p/Share
15,000 Added 50.0%
15,000 Common Stock
Apr 27 2021
SELL
Open market or private sale
$887,000 $35.48 p/Share
25,000 Reduced 100.0%
0 Common Stock
Apr 27 2021
BUY
Exercise of conversion of derivative security
$47,250 $1.89 p/Share
25,000 Added 50.0%
25,000 Common Stock
Apr 19 2021
SELL
Open market or private sale
$776,250 $31.05 p/Share
25,000 Reduced 100.0%
0 Common Stock
Apr 19 2021
BUY
Exercise of conversion of derivative security
$47,250 $1.89 p/Share
25,000 Added 50.0%
25,000 Common Stock
Apr 08 2021
SELL
Open market or private sale
$368,908 $38.36 p/Share
9,617 Reduced 100.0%
0 Common Stock
Apr 08 2021
BUY
Exercise of conversion of derivative security
$18,176 $1.89 p/Share
9,617 Added 50.0%
9,617 Common Stock
Apr 07 2021
SELL
Open market or private sale
$605,475 $39.36 p/Share
15,383 Reduced 100.0%
0 Common Stock
Apr 07 2021
BUY
Exercise of conversion of derivative security
$29,074 $1.89 p/Share
15,383 Added 50.0%
15,383 Common Stock

Also insider at

CDAK
Codiak BioSciences, Inc. Healthcare
Chief Medical Officer
RXRX
RECURSION PHARMACEUTICALS, INC. Healthcare
Chief Medical Officer
DJM

David J Mauro

Chief Medical Officer
Cambridge, MA

Track Institutional and Insider Activities on PRLD

Follow Prelude Therapeutics Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PRLD shares.

Notify only if

Insider Trading

Get notified when an Prelude Therapeutics Inc insider buys or sells PRLD shares.

Notify only if

News

Receive news related to Prelude Therapeutics Inc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PRLD